CF

Cantor Fitzgerald Portfolio holdings

AUM $4.07B
1-Year Return 57.22%
This Quarter Return
+24.02%
1 Year Return
+57.22%
3 Year Return
+150.42%
5 Year Return
10 Year Return
AUM
$2.62B
AUM Growth
+$1.51B
Cap. Flow
+$1.19B
Cap. Flow %
45.54%
Top 10 Hldgs %
89.34%
Holding
336
New
128
Increased
30
Reduced
29
Closed
80

Sector Composition

1 Technology 66.6%
2 Consumer Discretionary 12.22%
3 Communication Services 7.12%
4 Financials 4.08%
5 Industrials 1.67%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
AZN icon
251
AstraZeneca
AZN
$253B
-148,226
Closed -$11.5M
BBWI icon
252
Bath & Body Works
BBWI
$6.06B
-11,403
Closed -$364K
BIL icon
253
SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$42B
-3,375
Closed -$310K
BKTI icon
254
BK Technologies
BKTI
$248M
-15,700
Closed -$342K
CDLX icon
255
Cardlytics
CDLX
$49.6M
-57,200
Closed -$183K
CHX
256
DELISTED
ChampionX
CHX
-26,071
Closed -$786K
CIF
257
MFS Intermediate High Income Fund
CIF
$31.3M
-10,000
Closed -$17.8K
CMPS
258
Compass Pathways
CMPS
$493M
-10,000
Closed -$63K
CORZ icon
259
Core Scientific
CORZ
$4.16B
-116,175
Closed -$1.38M
CPRI icon
260
Capri Holdings
CPRI
$2.53B
-110,778
Closed -$4.7M
ELVN icon
261
Enliven Therapeutics
ELVN
$1.19B
-33,088
Closed -$845K
ESGR
262
DELISTED
Enstar Group
ESGR
-6,786
Closed -$2.18M
EW icon
263
Edwards Lifesciences
EW
$47.5B
0
EWJ icon
264
iShares MSCI Japan ETF
EWJ
$15.5B
-5,788
Closed -$414K
EWTX icon
265
Edgewise Therapeutics
EWTX
$1.64B
0
EXFY icon
266
Expensify
EXFY
$178M
-32,070
Closed -$62.9K
GAN
267
DELISTED
GAN Ltd
GAN
-100,000
Closed -$177K
HUYA
268
Huya Inc
HUYA
$796M
-12,000
Closed -$61.2K
HYGW icon
269
iShares High Yield Corporate Bond BuyWrite Strategy ETF
HYGW
$224M
-15,000
Closed -$492K
ILCV icon
270
iShares Morningstar Value ETF
ILCV
$1.09B
0
IMCR icon
271
Immunocore
IMCR
$1.87B
-101,942
Closed -$3.17M
IMUX icon
272
Immunic
IMUX
$75.1M
-13,000
Closed -$21.5K
INDA icon
273
iShares MSCI India ETF
INDA
$9.26B
-6,166
Closed -$361K
IOVA icon
274
Iovance Biotherapeutics
IOVA
$901M
0
KROS icon
275
Keros Therapeutics
KROS
$633M
0